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Abstract
Background: Dengue virus (DENV) was reintroduced into Brazil in 1986 and by 1995 it had spread throughout the country.
In 2007 the number of dengue hemorrhagic fever (DHF) cases more than doubled and a shift in the age distribution was
reported. While previously the majority of DHF cases occurred among adults, in 2007 53% of cases occurred in children
under 15 years old. The reasons for this shift have not been determined.
Methods and Findings: Age stratified cross-sectional seroepidemiologic survey conducted in Recife, Brazil in 2006.
Serostatus was determined by ELISA based detection of Dengue IgG. We estimated time-constant and time-varying forces
of infection of DENV between 1986 and 2006. We used discrete-time simulation to estimate the accumulation of monotypic
and multitypic immunity over time in a population previously completely susceptible to DENV. We projected the age
distribution of population immunity to dengue assuming similar hazards of infection in future years. The overall prevalence
of DENV IgG was 0.80 (n = 1427). The time-constant force of infection for the period was estimated to be 0.052 (95% CI
0.041, 0.063), corresponding to 5.2% of susceptible individuals becoming infected each year by each serotype. Simulations
show that as time since re-emergence of dengue goes by, multitypic immunity accumulates in adults while an increasing
proportion of susceptible individuals and those with monotypic immunity are among young age groups. The median age of
those monotypically immune can be expected to shift from 24 years, 10 years after introduction, to 13 years, 50 years after
introduction. Of those monotypically immune, the proportion under 15 years old shifts from 27% to 58%. These results are
consistent with the dengue notification records from the same region since 1995.
Interpretation: Assuming that persons who have been monotypically exposed are at highest risk for severe dengue, the
shift towards younger patient ages observed in Brazil can be partially explained by the accumulation of multitypic immunity
against DENV-1, 2, and 3 in older age groups, 22 years after the re-introduction of these viruses. Serotype specific
seroepidemiologic studies are necessary to accurately estimate the serotype specific forces of infection.
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Introduction
Dengue infection constitutes a major threat for urban
populations of Latin America and Asia [1],[2]. Important
differences in the clinical and epidemiological profile of dengue
between the countries of Latin America and Southeast (SE) Asian
have been observed. While in SE Asian countries dengue
hemorrhagic fever (DHF) is common and morbidity and mortality
has traditionally concentrated in children under 15 years of age, in
American countries the disease affects mostly adult populations
and manifests primarily as dengue fever (DF) [3,4].
Several hypotheses have been proposed to explain these
differences. It has been shown that children from Central America,
Venezuela, and Colombia may not develop vascular permeability
as readily as children from SE Asia after secondary dengue
infection,[5–6] and that there may be a high prevalence of dengue
resistance genes among black populations of Brazil and the
Caribbean [7,8]. An additional explanation for the low numbers of
DHF in American countries may be underreporting of cases that
do occur, due to technical difficulties or a limited capacity to
perform diagnosis that meet the criteria of the WHO case
definition [3]. None of these explanations are fully satisfactory in
explaining the differences between the two regions.
Dengue was reintroduced in Brazil in 1986, after an absence of at
least 20 years (except for an epidemic in Roraima in 1981 and
sporadic cases). Since then, Brazil has become the country that
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reports the largest number of cases to the WHO, accounting for over
70% of cases reported in the Americas [9,10]. Three serotypes
currently circulate throughout the country; DENV 1 was reintro-
duced to Rio de Janeiro in 1986, DENV 2 in 1990, and DENV 3 in
2002, and from Rio they spread to the rest of the country[11]. While
prior to 2007 the majority of DHF cases in Brazil occurred among
adults aged 20–40 years of age, in 2007 the annual number of DHF
cases more than doubled over previous years and a shift in the age
distribution was reported [12]. In 2007, 53% of cases occurred in
children under 15 years old. The shift was most noticeable in the
Northeast region, where children accounted for 65% of the total
number of DHF cases, while other regions such as the Central-West
and North did not experience a significant shift and most of the DHF
cases continued to occur among adults [12].
Although the cause of this shift is likely to be multifactorial, we
propose that the conditions for it were being set gradually since the
re-emergence of DENV in 1986 and that the current epidemio-
logical profile represents the transition from re-emergence to
hyperendemicity. In a setting where transmission is constant,
people who are exposed for a longer time have a greater
cumulative probability of infection. In Brazil, circulation of DENV
virus for over 20 years has resulted in the accumulation of
immunity in older individuals, driving the average age of primary
and secondary infection towards younger age groups.
Using data from a serological study performed in Recife, in
Northeast Brazil, we estimate the force of infection and basic
reproductive number of dengue in three areas of distinct socio-
economic status for the period 1986–2006, in order to better
Author Summary
The spread of dengue virus is a major public health
problem. Though the burden of dengue has historically
been concentrated in Southeast Asian countries, Brazil has
become the country that reports the largest number of
cases in the world. While prior to 2007 the disease affected
mostly adults, during the 2007 epidemic the number of
dengue hemorrhagic fever cases more than doubled, and
over 53% of cases were in children under 15 years of age.
In this paper, we propose that the conditions for the shift
were being set gradually since the re-introduction of
dengue in 1986 and that they represent the transition from
re-emergence to hyperendemicity. Using data from an age
stratified seroprevalence study conducted in Recife, we
estimated the force of infection (a measure of transmission
intensity) between 1986–2006 and used these estimates to
simulate the accumulation of immunity since the re-
emergence. As the length of time that dengue has
circulated increases, adults have a lower probability of
remaining susceptible to primary or secondary infection
and thus, cases become on average younger. If in fact the
shift represents the transition from re-emergence to
hyperendemicity, similar shifts are likely to be observed
in the rest of Brazil, the American continent and other
regions where transmission emerges.
Figure 1. Age specific seroprevalence of dengue in Recife, 2006. Age-specific seroprevalence data a) for the whole sample and b) for each
specific area. The lines show the fit of 1) constant (red lines) and 2) time-varying models (green lines) to the age-specific seroprevalence data (black
dots). 95% confidence intervals of seroprevalence data are shown by the dotted vertical lines.
doi:10.1371/journal.pntd.0000935.g001
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understand transmission intensity over this period. We then use these
estimates to simulate the accumulation of monotypic and multitypic
immunity in a population previously susceptible to dengue virus, and
to predict the expected age distribution of DHF cases in the future.
Materials and Methods
Ethics statement
This study was reviewed and approved by the ethics committee
of the CPqAM-Fiocruz/Brazilian Ministry of Health (No. 49/04).
Written consent to participate in the study was obtained from each
person (or their guardian) after a full explanation of the study was
provided. All personal identifiers were removed prior to secondary
data analysis at Johns Hopkins University.
Data sources
This study was based on a serological sample of households in
Recife, Pernambuco, Brazil, conducted between August and
September 2006. The first dengue outbreak in the state of
Pernambuco occurred in 1987 (DENV 1). No additional autochtho-
nous cases were reported until 1995, when DENV 2 was introduced
causing a new epidemic. Since 1995 cases have been reported every
year. DENV 3 was first isolated in Pernambuco in 2002 [13].
The study population and methods have been described in detail
by Braga et al. [14] Briefly, Recife has 1.5 million inhabitants. The
climate is humid, with an average temperature of 25uC and rainfall
of approximately 2000 mm per year. Three neighborhoods were
selected to represent low, medium and high socio-economic areas. A
systematic age stratified sample was obtained, using the Census
2000 data that provides the total population size, number of
households and age distribution in the three areas [15]. Residents
aged between 5 and 64 years were eligible for the survey. Serum
samples were screened for IgG antibodies against DENV with an
enzyme-linked immunoassay commercial kit (Dengue IgG-ELISA,
PanBio, Ltd., Brisbane, Australia). Tests were performed in
duplicate according to the manufacturer’s instructions. This test
does not determine the presence of immunity to specific dengue
serotypes, but the presence of immunity to any dengue serotype.
Estimating the force of infection
The force of infection (l) is a measure used to characterize the
intensity of transmission in a given setting and estimates the per
capita rate of acquisition of infection by susceptible individuals.
Age stratified serological surveys can provide information about
the force of infection over a period of time, l(t), as described
elsewhere [16]. Assuming that the risk of infection does not vary
with age, the difference in seroprevalence between subjects a and
a+1 years of age can be attributed to the transmission intensity
between a and a+1 years ago. To estimate l(t), for the period
1986–2006, we used a model based upon one described by
Ferguson et al.[17] We estimated constant and time-varying forces
of infection. Detailed information regarding the methods used can
be found in Text S1 in Supporting Information S1.
Estimating the basic reproductive number (R0)
R0 is the number of secondary infections generated by a primary
case in a completely susceptible population. R0 gives insight into the
level of control that is required to reduce incidence and eventually
block transmission. Detailed information regarding the methods used
to estimate R0 can be found in Text S1 in Supporting Information S1.
Figure 2. Estimated average time-varying forces of infection. a) Estimated average time-varying forces of infection (FI), with 95% confidence
intervals for Recife over the period 1986–2006. b). Estimated time varying-forces of infection for the three sampled neighborhoods over the period 1986–2001.
doi:10.1371/journal.pntd.0000935.g002
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Immunologic shift simulations
To estimate the accumulation of monotypic and multitypic
immunity in a population previously susceptible to dengue, we
performed a discrete-time simulation by applying the forces of
infection estimated from the seroprevalence data onto a simulated
immunologically naive population structured by-age like the one
of Recife. We used independent data on the years in which the
different serotypes were introduced into Brazil/Pernambuco to
apply the estimated hazards only in those years when particular
serotypes were known to have circulated [11,13]. The age profile
of the population was obtained from the 2000 census data. We
conducted simulations until age distributions of immunity reached
equilibrium and used both constant and time-varying hazards.
Since we did not have seroprevalence data to estimate the force of
infection beyond 2006, we assumed that l(t) after 2006 has been
constant and equal to the average hazard over the period 1986–2006.
All statistical analyses were performed using R statistical
package (version 2.10.1).
Results
The dataset contained data on 1427 subjects aged 5 to 20 years,
593 (41.6%) from area 1, 480 (33.6%) from area 2 and 342 (24.0%)
from area 3. Figure 1 shows the age-specific seroprevalences of each
of the areas (black dots). Area 1, the neighborhood of low
socioeconomic status showed a significantly higher seroprevalence
when compared to Area 3, the high socioeconomic stratum
neighborhood (0.85 (95%CI 0.82–0.88) vs. 0.70 (95%CI 0.65–
0.75), p,0.0001). The middle class neighborhood (Area 2) also
showed a significantly higher seroprevalence when compared to Area
3 (0.82 vs. 0.70, p=0.0002). Based on the seroprevalence and that
approximately 87000 cases were notified in Recife during this period,
it is clear that less then 10% of the infections were reported [13].
Force of infection
The estimated average time-constant force of infection for the
period 1986–2006 was 0.052 (95% CI 0.041–0.063). On average,
each serotype infected 5.2% of susceptible individuals each year.
Time constant ls for the three areas were 0.068 (95%CI 0.045,
0.091), 0.056 (95%CI 0.035, 0.077) and 0.035 (95%CI 0.019,
0.051). Though the difference between these forces of infection is
not statistically significant, a trend is seen towards higher hazards
of infection in settings of lower socioeconomic status.
As can be expected, the fit of the model improved significantly
when we allowed for time-varying forces of infection (likelihood
ratio test, p = 0.006). According to this model (Figure 2), the
average yearly force of infection ranged between 0 and 0.057
between 1986 and 1998, and then peaked at 0.26 in 1999. As has
been reported elsewhere the correlation between incidence and
estimated force of infection is poor (r = 0.21) [18].
Given that it has been reported that between 1987 and 1995
there were no autochthonous dengue cases in the state of
Figure 3. Discrete time simulation shows that as years go by, multitypic immunity accumulates among adults. Results of discrete-time
simulation to show the accumulation of multitypic and monotypic immunity 10, 20, and 30 years after the introduction of dengue virus into a
previously susceptible population, and at equilibrium. l (DENV 1, 2 and 3) = 0.05.
doi:10.1371/journal.pntd.0000935.g003
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Pernambuco, we also fit a model constraining the force of infection
for these years to be 0 [13]. The fit of this 8-parameter model was
not significantly different from the fit of the model that did not
constrain these hazards to be zero (LR test, p = 0.99) or from the
saturated model (LR test, p = 0.34).
Figure 1 shows the fit of 1) constant (red lines) and 2) time-
varying models (green lines) to the age-specific seroprevalence data
in the three areas and overall areas.
The correlation between the annual hazards estimated in areas
1 and 3 (r = 0.79) is high, while the correlation between 1 and 2
and between 2 and 3 is poor (r = 0.06 and 0.18, respectively).
Basic reproductive number
Using the time constant and time varying ls we estimated an
overall R0 of dengue in Recife of 2.7 (95%CI 2.45, 3.11). For the
three areas the R0 estimates were 3.3 (95%CI 2.45, 4.18), 2.8
(95%CI 2.09, 3.64) and 2.1 (95%CI 1.56, 2.66), respectively.
Simulations
Figure 3 shows the age distribution of susceptible, monotypically
immune and multitypically immune at different time-points after
the introduction of DENV 1, 2 and 3 into a previously susceptible
population, assuming a constant risk of infection of 0.052/year/
serotype. As the number of years of DENV circulation increases,
multitypic immunity accumulates among adults, and susceptibles
and monotypically immune become increasingly concentrated in
younger age groups.
Assuming that cases of DHF occur primarily among people who
experience secondary infection, the age distribution of people who
are at risk of secondary infection (i.e. of people who have been
exposed to a single dengue serotype) should approximate the age
distribution of DHF cases [19]. Hence, our results suggest that as
years after re-emergence go by, the mean, median and modal ages
of cases will decrease. Forl =0.052, the model estimates that
while 10 years after re-emergence the median, mean and modal
age of cases (monotypically immune) would be 24, 29.0 and 14
years respectively, these numbers would decrease to 13, 15.2 and
11 years 50 years after re-emergence. Similarly, while it is
expected that only up to 27% of DHF cases would occur in
children under 15 years of age 10 years after the re-emergence, 50
years after re-emergence this proportion would increase to 58%.
Figure 4 shows the age distribution of hospitalized dengue cases in
Pernambuco in 2007, based on official notification records, and
the estimated distribution according to our model (20 years after
re-emergence) [20].
The strength and the speed of the shift in the age distribution of
immunity depend on the underlying force of infection (Figure 5
and Table S1 in Supporting Information S1). The estimated
Figure 4. Age distribution of hospitalized dengue cases in Brazil, 2007 resembles expected age distribution of monotypically
immune. Age distribution of hospitalized dengue cases in Pernambuco, 2007 [20] (top). Age distribution of monotypically immune, 20 years after
the introduction of dengue virus into a previously susceptible population, as predicted by the model (bottom). l (DENV 1, 2 and 3) = 0.05.
doi:10.1371/journal.pntd.0000935.g004
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median and modal ages of monotypically immune for l=0.03 are
19 and 15 years respectively, 50 years after re-emergence, while
these ages drop to 11 and 6 years for l=0.07.
Results were similar if time-varying, instead of constant forces of
infection were applied, or if l for each serotype was weighted
taking into account the serotype predominance reported for the
different years in the state of Pernambuco [13].
Discussion
A dramatic increase in the number of DHF cases and a shift in
age group predominance of DHF were observed during the 2007
dengue epidemic in Brazil, the first re-emergence of the DENV-2
serotype predominance since 1990. Our results suggest that this
shift can be partly explained by the accumulation of multitypic
immunity in the adult population over time after the re-emergence
of DENV-1 in 1986, DENV-2 in 1990 and DENV-3 in 2002. As
the length of time of co-circulation of multiple serotypes of dengue
in Brazil increases, adults have a lower probability of remaining
susceptible to infection. As a result, cases become on average
younger as completely susceptible individuals and monotypically
immune individuals are more likely to be from younger age
groups.
If the accumulation of multitypic immunity in adult population is
in part responsible for the observed shift in age group predominance
of severe dengue cases, we would expect similar shifts to have
occurred in central and northern South America, where several
DENV serotypes have been known to circulate since the 1970’s. In
Mexico, Venezuela, Nicaragua and Colombia most of the severe
cases occur among children ,15 years of age and a similar trend is
being observed in Honduras.[21,22],[23]. In contrast, such a trend
has not been observed in countries where multiple serotypes only
started circulating in the 90’s. If the central/west regions of Brazil
continue to experience high DENV forces of infection and multiple
circulating serotypes we expect a similar shift in age group
predominance to occur in the coming years.
Since DHF is more likely to occur in children, a decrease in the
mean age of secondary infection might also be expected to lead to
an increase in the proportion of dengue infections that lead to
severe symptoms or DHF cases [24,25]. In the 1990’s, after
DENV-2 was introduced, 0.06% of reported dengue cases in
Brazil resulted in DHF/DSS. This percentage increased to 0.21%
in 2007 [9]. This observed increase in DHF may also have been a
result of changes in virulence of particular dengue viruses that
were circulating or due to the fact that the overall force of infection
has increased as has been proposed.
According to our model, the speed of the shift is proportional to
the magnitude of the average force of infection. Higher average
forces of infection lead to a more rapid shift of the age distributions
of immunity and to a younger median and modal age of
monotypically immune. Thus, the shift can be expected to be
slower in regions that have been exposed to weaker forces of
infection or where the re-emergence of multiple serotypes was
delayed. This may explain why the shift has only been observed in
major cities and certain regions of Brazil. The Northeast region of
Brazil, where Recife is located, has the highest proportion of
children among DHF cases, and it has also been traditionally the
region with the highest incidence rates of dengue fever since 1986
[9,12]. The Central-West region, where the shift is not yet
apparent has shown high incidence rates of dengue fever only
during the last 7 years [9].
Our estimate of the average l and R0 in Recife is lower than
those estimated for Thailand for the period 1980–2005 (l=0.1,
R0 = 5.2) [26]. Our model predicts that average forces of infection
of 0.1 would be associated with a mean age of severe or DHF cases
of 8 years, and this is consistent with what has been traditionally
observed in SE Asian countries. Both Thailand and Singapore
have experienced significant decreases in transmission intensity
over the last few years that have been accompanied by an increase
in the average age of cases [26],[27],[28]. If the force of infection
in Recife continues to be as high as it has been over the last 20
years, or higher, it is likely that within the next decade the age
distribution of DHF in Recife (and other American regions with
high forces of infection) will resemble the age distribution observed
in SE Asia, with most cases concentrated in the adolescent
population. However, our projections are meant to be qualitative
rather than quantitative. The actual seroprevalences observed in
the future in Recife may differ from our projections depending on
secular trends in the transmission intensity of dengue and
population demographics.
There are several limitations to this study. Even though our
results present an explanation for why DHF may have shifted
towards children over the years since introduction, the mechanism
that we propose is gradual and does not explain the sudden change
observed in 2007–2008. The recirculation of DENV-2 into certain
Figure 5. Predicted changes in the age distribution of
monotypically immune (DHF/DSS) over time. Estimated mean
age of monotypically immune (top) and proportion of monotypically
immune (DHF/DSS cases) that are children under 15 years (bottom) at
several time points after the introduction of DENV into a previously
susceptible population.
doi:10.1371/journal.pntd.0000935.g005
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cities in 2007, after almost 7 years of DENV 3 predominance and
the resultant increase in secondary cases may have determined the
observation of an age shift in 2007 and not before, even though it
had been gradually taking place [9]. As reported by the Ministry of
Health, during 1998–2006 the percentage of severe dengue cases
in children increased from 9.5% (in 1998) to 22.6% (in 2001).
Although our results suggest that the major driver of the shift is the
accumulation of immunity in older age groups, fluctuations in
serotype specific transmission intensity, serotype predominance,
characteristics of the virus or serotype predominance may have
also played a role in determining the visibility of the shift.
Our model predicts that after 20 years of exposure to a constant
force of infection of 0.05 per year, children 15 years old or younger
should only account for 31% of DHF cases while the data shows
that in 2007, 70% of cases in Recife occurred among children of
this age group. This discrepancy may arise due to the fact that the
model does not take into account age-dependence of infection or
clinical presentation. If children are more likely to develop severe
disease, then the observed distribution of cases is likely to be
skewed towards lower age groups.
The fact that the available serological study does not contain
serotype specific information limits our ability to estimate serotype
specific forces of infection, interactions (enhancement/inhibition)
and basic reproductive numbers. Similarly, the cross-sectional
nature of this dataset does not allow us to control for potential
confounding by age dependent transmission intensity. Longitudi-
nal data and data from seroprevalence studies using serotype
specific methods such as the PRNT are essential in order to
properly reconstruct the transmission intensity over the last 20
years.
This analysis has important public health implications on
planning public health responses to dengue for the next decade.
Dengue is the most rapidly spreading vector borne viral disease. If
the age shift in fact represents the transition from re-emergence to
hyperendemicity, similar shifts in age are likely to be observed in
the rest of Brazil, the American continent and other regions where
dengue has emerged more recently.
Supporting Information
Supporting Information S1 Detailed methods and additional
results.
Found at: doi:10.1371/journal.pntd.0000935.s001 (0.07 MB
DOC)
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